Publicacions en què col·labora amb Aitana Elena Tamayo Hernando (15)

2022

  1. Bigels as drug delivery systems: From their components to their applications

    Drug Discovery Today, Vol. 27, Núm. 4, pp. 1008-1026

  2. Eudragit® L100/chitosan composite thin bilayer films for intravaginal pH-responsive release of Tenofovir

    International Journal of Pharmaceutics, Vol. 616

  3. Optimized hydration dynamics in mucoadhesive xanthan-based trilayer vaginal films for the controlled release of tenofovir

    Carbohydrate Polymers, Vol. 278

  4. Silicon Oxycarbide Porous Particles and Film Coating as Strategies for Tenofovir Controlled Release in Vaginal Tablets for HIV Prevention

    Pharmaceutics, Vol. 14, Núm. 8

2021

  1. Silane modification of mesoporous materials for the optimization of antiviral drug adsorption and release capabilities in vaginal media

    Pharmaceutics, Vol. 13, Núm. 9

  2. Smart vaginal bilayer films of Tenofovir based on Eudragit® L100/natural polymer for the prevention of the sexual transmission of HIV

    International journal of pharmaceutics, Vol. 602, pp. 120665

2020

  1. Amino functionalized micro-mesoporous hybrid particles for the sustained release of the antiretroviral drug tenofovir

    Materials, Vol. 13, Núm. 16

  2. Development and In Vitro/Ex Vivo Characterization of Vaginal Mucoadhesive Bilayer Films Based on Ethylcellulose and Biopolymers for Vaginal Sustained Release of Tenofovir

    Biomacromolecules, Vol. 21, Núm. 6, pp. 2309-2319

  3. Mucoadhesive vaginal discs based on cyclodextrin and surfactants for the controlled release of antiretroviral drugs to prevent the sexual transmission of HIV

    Pharmaceutics, Vol. 12, Núm. 4

  4. Vaginal polyelectrolyte layer-by-layer films based on chitosan derivatives and Eudragit® S100 for pH responsive release of tenofovir

    Marine Drugs, Vol. 18, Núm. 1

2019

  1. Chitosan-based mucoadhesive vaginal tablets for controlled release of the anti-HIV drug tenofovir

    Pharmaceutics, Vol. 11, Núm. 1

2018

  1. Optimization of tenofovir release from mucoadhesive vaginal tablets by polymer combination to prevent sexual transmission of HIV

    Carbohydrate Polymers, Vol. 179, pp. 305-316

2017

  1. Influence of chitosan swelling behaviour on controlled release of tenofovir from mucoadhesive vaginal systems for prevention of sexual transmission of HIV

    Marine Drugs, Vol. 15, Núm. 2

2015

  1. Chitosan and Kappa-Carrageenan Vaginal Acyclovir Formulations for Prevention of Genital Herpes. In Vitro and Ex Vivo Evaluation

    Marine Drugs, Vol. 13, Núm. 9, pp. 5976-5992

  2. Mesoporous silicon oxycarbide materials for controlled drug delivery systems

    Chemical Engineering Journal, Vol. 280, pp. 165-174